Restart Life Sciences(FRA) HN30

Market Cap€2.35M

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

€0.04

+0.00%

+0.00Today

Restart Life Sciences Financials at a Glance

Market Cap

€2.35M

Revenue (TTM)

€0.29

Net Income (TTM)

-€1.06

EPS (TTM)

-€0.02

P/E Ratio

-2.98

Dividend

€0.00

Beta (Volatility)

-1.12 (Low)

Dividend

€0.00

Beta (Volatility)

-1.12 (Low)

Price

€0.04

Volume

Open

€0.04

Price

€0.04

Volume

Open

€0.04

Previous Close

€0.04

Daily Range

€0.04 - €0.04

52-Week Range

€0.03 - €0.08

Estimated Earnings Date

N/A

Dividend

€0.00

Beta (Volatility)

-1.12 (Low)

Price

€0.04

Volume

Open

€0.04

Previous Close

€0.04

Daily Range

€0.04 - €0.04

52-Week Range

€0.03 - €0.08

Estimated Earnings Date

N/A

HN30 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Restart Life Sciences

Nova Mentis Life Science Corp. is a biotechnology company, which engages in building and supporting a diversified portfolio of cannabis-sector businesses. It provides funding, management, HR resources, and marketing expertise to the companies. The firm also forms relationships with organizations engaged in research and development of cannabis uses and products. The company was founded on October 27, 2004 and is headquartered in Vancouver, Canada.

Industry

Biotechnology

Sector

Health Care

CEO

Steve Loutskou

Website

www.restartlife.co

HN30 Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

-248.38%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

-33.56%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€2.35M

Shares Outstanding

61.08M

Volume

Avg. Volume

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Restart Life Sciences Performance Analysis

Restart Life Sciences annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	EUR 0	N/A
2023	2023-12-31	EUR 0	N/A
2024	2024-12-31	EUR 0	N/A
2025	2025-12-31	EUR 0	N/A

Restart Life Sciences annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	EUR -0.13	-19.0%
2023	2023-12-31	EUR -0.06	-56.7%
2024	2024-12-31	EUR 0.01	N/A
2025	2025-12-31	EUR -0.03	N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

€0.21

N/A

Gross Profit

-€0.44

+1503.0%

Gross Margin

-213.33%

N/A

Market Cap

€2.35M

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-€0.63

+4.9%

EBITDA

-€0.55

+5.3%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

€0.61

+488.0%

Total Debt

€0.21

N/A

Accounts Receivable

€0.06

N/A

Inventory

€0.09

N/A

Long Term Debt

€0.00

N/A

Short Term Debt

€0.21

N/A

Return on Assets

-157.83%

+0.4%

Return on Invested Capital

-1381.11%

+0.9%

Free Cash Flow

-€0.31

+7.2%

Operating Cash Flow

-€0.31

+7.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,684.24-0.00%

^DJIDJI

^DJIDJI$53,254.61-0.01%

^IXICNASDAQ

^IXICNASDAQ$26,319.55-0.00%

BTCBitcoin

BTCBitcoin$78,890.00-0.00%

SPCXSPCX

SPCXSPCX$142.81+0.01%

AAPLAAPL

AAPLAAPL$315.25-0.01%

AMZNAMZN

AMZNAMZN$258.45-0.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PCGPG&E

PCGPG&E$13.27-0.20%

NVDANvidia

NVDANvidia$220.78+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.97+0.11%

CNHCNH Industrial

CNHCNH Industrial$11.83+0.01%

NUNu Holdings

NUNu Holdings$14.55+0.02%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.63+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.43-0.02%

Questions About HN30

What is the current price of Restart Life Sciences?

Restart Life Sciences is trading at €0.04 per share.

What is the 52-week range for Restart Life Sciences?

Over the past 52 weeks, Restart Life Sciences has traded between €0.03 and €0.08.

How much debt does Restart Life Sciences have?

As of the most recent reporting period, Restart Life Sciences reported total debt of €214.76K.

How much cash does Restart Life Sciences have on hand?

Restart Life Sciences reported €392.53K in cash and cash equivalents in its most recent financial results.

What is Restart Life Sciences’s dividend yield?

Restart Life Sciences does not currently have a dividend yield.

Restart Life Sciences(FRA) HN30

Restart Life Sciences Financials at a Glance

HN30 News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Restart Life Sciences

HN30 Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Restart Life Sciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About HN30

What is the current price of Restart Life Sciences?

What is the 52-week range for Restart Life Sciences?

How much debt does Restart Life Sciences have?

How much cash does Restart Life Sciences have on hand?

What is Restart Life Sciences’s dividend yield?

Premium Investing Services